P3 Health Partners Revenue 2020-2025 | PIII
P3 Health Partners revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
P3 Health Partners Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,500 |
| 2023 | $1,266 |
| 2022 | $1,049 |
| 2021 | $637 |
| 2020 | $491 |
| 2019 | $145 |
|
P3 Health Partners Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $345 |
| 2025-06-30 | $356 |
| 2025-03-31 | $373 |
| 2024-12-31 | $371 |
| 2024-09-30 | $362 |
| 2024-06-30 | $379 |
| 2024-03-31 | $388 |
| 2023-12-31 | $347 |
| 2023-09-30 | $288 |
| 2023-06-30 | $329 |
| 2023-03-31 | $302 |
| 2022-12-31 | $258 |
| 2022-09-30 | $248 |
| 2022-06-30 | $269 |
| 2022-03-31 | $274 |
| 2021-12-31 | $185 |
| 2021-09-30 | $156 |
| 2021-06-30 | $145 |
| 2021-03-31 | $151 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.018B | $1.500B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.493B | 42.21 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.649B | 31.50 |
| Hims & Hers Health (HIMS) | United States | $6.743B | 54.85 |
| IRhythm Holdings (IRTC) | United States | $5.166B | 0.00 |
| Hinge Health (HNGE) | United States | $3.350B | 0.00 |
| Privia Health (PRVA) | United States | $2.945B | 184.15 |
| 10x Genomics (TXG) | United States | $2.832B | 0.00 |
| Heartflow (HTFL) | United States | $2.739B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.307B | 38.17 |
| Omnicell (OMCL) | United States | $2.257B | 46.15 |
| Azenta (AZTA) | United States | $1.842B | 75.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.316B | 6.91 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.139B | 0.00 |
| Phreesia (PHR) | United States | $0.955B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.860B | 0.00 |
| Talkspace (TALK) | United States | $0.671B | 135.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.318B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 14.22 |
| Senseonics Holdings (SENS) | United States | $0.299B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.260B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.160B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.159B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| American Well (AMWL) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.059B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Movano (MOVE) | United States | $0.014B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |